Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot-Reference-Cited by-同舟云学术

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot

Published:2022-02 Issue:2 Volume:23 Page:270-278
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Pilonis Nastazja Dagny,Killcoyne Sarah,Tan W Keith,O'Donovan Maria,Malhotra Shalini,Tripathi Monika,Miremadi Ahmad,Debiram-Beecham Irene,Evans Tara,Phillips Rosemary,Morris Danielle L,Vickery Craig,Harrison Jon,di Pietro Massimiliano,Ortiz-Fernandez-Sordo Jacobo,Haidry Rehan,Kerridge Abigail,Sasieni Peter D,Fitzgerald Rebecca C

Funder

MRC

Cancer Research UK

Innovate UK

Publisher

Elsevier BV

Subject

Oncology

Reference27 articles.

1. Missed opportunities for screening and surveillance of Barrett's esophagus in veterans with esophageal adenocarcinoma;Hammad;Dig Dis Sci,2019

2. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study;Arnold;Lancet Oncol,2019

3. Barrett oesophagus;Peters;Nat Rev Dis Primers,2019